AUTH/3424/11/20: Anonymous v GlaxoSmithKline (GP Online ‘Sponsored by GSK’ asthma inhalers article and lowcarboninhalers.co.uk) – No breach on appeal

📅 2020 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/3424/11/20
PartiesAnonymous v GlaxoSmithKline
SubjectGP Online sponsored article about switching asthma inhalers to cut carbon emissions; linked lowcarboninhalers.co.uk HCP website
Applicable Code year2019
Complaint received13 November 2020
Case completed16 September 2021
Panel decisionBreach of Clauses 9.10 and 9.1 for the GP Online article; no breach for the website-related allegations
AppealGSK appealed the Panel’s rulings on Clauses 9.10 and 9.1
Appeal Board decisionNo breach of Clause 9.10; consequently no breach of Clause 9.1 (appeal successful)
Final outcomeNo breach of the Code
Materials referencedGP Online article ref NP-GB-RS-ADVR-190001; website ref NP-GB-RS-WCNT-190007 (as cited in complaint)

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, non-contactable complainant (self-described health professional) complained about a GP Online article on switching asthma inhalers to help the NHS cut carbon emissions.
  • The GP Online page displayed “Sponsored by GSK” above the title and a GSK logo; further down it stated “This article was initiated, funded and reviewed by GSK”, and similar wording appeared again at the bottom.
  • The complainant alleged the sponsorship declaration was unclear at first view and did not make GSK’s level of involvement (initiator/funder) sufficiently clear.
  • The article linked to lowcarboninhalers.co.uk (intended for UK health professionals). The complainant alleged the site was biased towards dry powder inhalers (DPIs), included an “18x” carbon footprint claim, provided “what can you do?” statements without references, lacked prescribing information and a compliant adverse event statement, and was one-sided/disparaging towards pMDIs.
  • GSK responded that both items were non-promotional/educational; the website discussed broad inhaler categories (pMDIs vs DPIs) without promoting specific medicines/devices, included a link to the NICE inhaler decision aid, and included an invitation to report adverse events.
⚖️

Outcome

  • Final outcome (after appeal): No breach of the Code.
  • The Panel initially ruled a breach for the GP Online article under Clauses 9.10 and 9.1, but GSK appealed.
  • The Appeal Board allowed the appeal and ruled no breach of Clause 9.10 and consequently no breach of Clause 9.1.
  • For the lowcarboninhalers.co.uk website, the Panel ruled no breach of Clauses 4.1, 4.6, 4.9, 7.2, 7.4, 8.1, 9.1, 12.1 and 14.1.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training